Funding Results
Fighting Blindness Canada (FBC) is the largest charitable funder of vision research in Canada. On this page, you will find information on grants FBC has awarded since 2015. Jump to: Research Grants…
BIOLOGICAL MECHANISMS DRIVING HDAC INHIBITOR TREATMENT EFFECTS IN RP
Valproic acid (VA), belongs to a family of drugs called HDAC inhibitors (HDACi) and has been tested as a potential treatment for retinitis pigmentosa (RP) with mixed results. In some clinical trials,…
Ruanne Vent-Schmidt: The blind and visually impaired can help researchers by getting their genes tested
Dr. Ruanne Vent-Schmidt is a PhD candidate in FBC funded Dr. Orson Moritz’s lab. She recently wrote an article for The Conversation about the importance of genetic testing. Read the full article…
From Bench to Bedside and Back Again: ARVO Comes to Canada
The phrase “from the bench to the bedside” is often used to describe the path to new medical treatments, beginning with a discovery at the laboratory “bench” and finishing when patients can…
Spotlight on ARVO 2019 with Ruanne Vent-Schmidt
This is a guest post by Ruanne Vent-Schmidt My name is Ruanne Vent-Schmidt and I am a PhD candidate in Dr. Orson Moritz’s lab. Fighting Blindness Canada (FBC) is funding Dr. Moritz’s…
On The Road to Personalized Therapies for Blindness: New Study Reveals Why Genetic Testing is Vital
Every day, my research is focused on developing an effective treatment for the blinding eye disease retinitis pigmentosa (RP). Recently, we made an alarming discovery: the SAME drug makes some genetic forms of…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.